Cargando…
The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting
Culprits of cancer development, metastasis, and drug resistance, cancer stem cells (CSCs) are characterized by specific markers, active developmental signaling pathways, metabolic plasticity, increased motility, invasiveness, and epithelial-mesenchymal transition. In breast cancer, these cells are o...
Autores principales: | Walker, Olivia L., Dahn, Margaret L., Power Coombs, Melanie R., Marcato, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807694/ https://www.ncbi.nlm.nih.gov/pubmed/35127497 http://dx.doi.org/10.3389/fonc.2021.791696 |
Ejemplares similares
-
Targeting the Roots of Recurrence: New Strategies for Eliminating Therapy-Resistant Breast Cancer Stem Cells
por: Dahn, Margaret L., et al.
Publicado: (2020) -
The Flick of a Switch: Conferring Survival Advantage to Breast Cancer Stem Cells Through Metabolic Plasticity
por: Walsh, Hayley R., et al.
Publicado: (2019) -
Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells
por: Jin, Kaipeng, et al.
Publicado: (2023) -
Correlation between Metabolite of Prostaglandin E2 and the incidence of colorectal adenomas
por: Jiang, Jia, et al.
Publicado: (2023) -
LncRNA PART1 Promotes Proliferation and Migration, Is Associated with Cancer Stem Cells, and Alters the miRNA Landscape in Triple-Negative Breast Cancer
por: Cruickshank, Brianne M., et al.
Publicado: (2021)